Answers are grounded in this paper and cite their sources.
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective of this review is to evaluate the benefits and harms of sugammadex compared to other neuromuscular blockade reversal agents (neostigmine and pyridostigmine) in infants and children undergoing surgical procedures. A secondary objective is to assess whether these outcomes differ by age group, comorbidities, co-medications, or type of neuromuscular blocking agent.
No takes yet. Share an insight, caveat, or question.
Raphael et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: